UROwebinar: From molecular environment to theranostics in hormone sensitive prostate cancer
|European School of Urology
Prostate cancer (PCa) is a heterogeneous neoplasm with different molecular signature profiles. Their identification is among the most difficult challenges in current research, but their clinical implications are broad. These encompass the discovery of new biomarkers in blood, urine or tissue samples, the expansion of radioligands for molecular imaging diagnosis and staging, and the development of targeted treatments including theranostic.
UROwebinar in collaboration with the EAU Section of Urological Imaging (ESUI) and the EAU Section of Urological Research (ESUR).
Contact our organiser
European School of Urology